Phase II Fixed Dose Rate Gemcitabine for Advanced or Metastatic Colorectal Cancer

Mise à jour : Il y a 4 ans
Référence : NCT00220155

Femme et Homme

Extrait

To assess the efficacy and safety of gemcitabine given by fixed dose rate intravenous infusion in patients with pretreated metastatic colorectal cancer.


Critère d'inclusion

  • Colorectal Cancer

Liens